openPR Logo
Press release

Automated Compounding Devices Market was valued at USD 445 million in 2024 and is projected to reach USD 920 million by 2034

12-09-2025 01:57 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Exactitude Consultancy

Automated Compounding Devices Market

Automated Compounding Devices Market

Market Overview
The Automated Compounding Devices Market was valued at USD 445 million in 2024 and is projected to reach USD 920 million by 2034, growing at a CAGR of 7.5% during the forecast period.

Automated compounding devices (ACDs) are advanced pharmacy automation systems designed to accurately mix and prepare sterile medications, such as parenteral nutrition, chemotherapy infusions, and other intravenous formulations. These systems improve safety, reduce human error, enhance workflow efficiency, and ensure compliance with strict regulatory standards.
Market growth is driven by rising demand for sterile compounding, increased adoption of automation in hospital pharmacies, higher patient safety requirements, and expanding use of personalized IV preparations.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/71627

Market Dynamics
Drivers
• Increasing prevalence of chronic diseases requiring long-term parenteral therapies.
• Rising need for sterile, contamination-free compounding in hospitals and specialty pharmacies.
• Growing focus on reducing medication errors and enhancing patient safety.
• High adoption of automation solutions to streamline pharmacy operations.
• Strong regulatory emphasis on compliance with USP 797 and 800 standards.

Restraints
• High capital investment required for automated compounding equipment.
• Significant maintenance and calibration costs.
• Limited adoption in small or budget-constrained healthcare facilities.
• Requirement for trained staff to operate and oversee automated systems.
• Integration challenges with existing hospital pharmacy information systems (PIS).

Opportunities
• Expansion of robotic compounding technologies with improved precision and real-time monitoring.
• Rising demand for home infusion therapy creating new opportunities for compact compounding systems.
• Growing adoption of AI-enabled compounding accuracy verification.
• Increasing investments in smart pharmacy automation ecosystems.
• Integration of closed-system transfer devices (CSTDs) enhancing safety for hazardous drug preparation.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/71627/automated-compounding-devices-market

Market Growth Outlook (2024-2034)
The ACD market will grow from USD 445 million in 2024 to USD 920 million by 2034, driven by rapid pharmacy automation, increasing outpatient infusion services, and stricter pharmaceutical compounding compliance requirements.
Future market expansion will be shaped by robotic compounding advancements, cloud-enabled monitoring, and rising demand for safer injectable therapies.

Segmentation Analysis
By Product Type
• Fully Automated Compounding Devices:
Used for large-volume compounding with high accuracy and minimal manual intervention.
• Semi-Automated Compounding Devices:
Suitable for medium-volume compounding and budget-conscious facilities.

By Application
Parenteral Nutrition:
• Major application for both total parenteral nutrition (TPN) and partial parenteral nutrition (PPN) compounding.
• Rising chronic illness burden fuels demand.
Chemotherapy & Hazardous Drug Preparation:
• Automated systems reduce occupational exposure and enhance sterility.
Intravenous Drug Compounding:
• Wide adoption across hospital pharmacies for routine IV formulations.

By End User
• Hospitals & Health Systems with centralized sterile compounding units.
• Outpatient Infusion Centers preparing personalized infusion therapies.
• Specialty & Compounding Pharmacies requiring high throughput and accuracy.
• Home-Care Infusion Providers increasingly adopting compact automated compounding units.

Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=71627

Regional Insights
North America
North America leads the market due to strong adoption of healthcare automation, strict regulatory standards, high compounding error-prevention emphasis, and widespread use of parenteral nutrition and chemotherapy.

Europe
Europe maintains strong growth supported by well-established hospital pharmacy systems, increasing automation investments, and stringent compounding quality regulations. Germany, France, the UK, and Italy are major markets.

Asia Pacific
Asia Pacific is the fastest-growing region, driven by rising hospital infrastructure, expanding cancer treatment services, and increasing adoption of sterile compounding automation in China, India, Japan, and South Korea.
Latin America & Middle East/Africa
Steady growth driven by modernization of healthcare systems, though adoption is slower due to high equipment costs and limited automation budgets.

Competitive Landscape
The market includes pharmacy automation leaders, sterile compounding technology developers, and medical device manufacturers.

Key Companies Include:
• B. Braun Melsungen AG
• Baxter International
• ICU Medical
• Omnicell
• Grifols
• Fresenius Kabi
• Parata Systems
• ARxIUM
• Equashield
• Codonics

These companies focus on automation technology innovation, improved compounding accuracy, hazardous drug handling safety, and AI-driven verification tools.

Recent Developments
• Introduction of next-generation robotic compounding units with advanced dose verification.
• Expansion of automated TPN preparation systems across major hospitals.
• Integration of barcode scanning, RFID tracking, and software-based safety checks.
• Increased use of CSTDs integrated with compounding automation for hazardous drug protection.
• Growing demand for cloud-connected pharmacy automation systems for remote monitoring and compliance reporting.

This report is also available in the following languages : Japanese (自動調合装置市場), Korean (자동 배합 장치 시장), Chinese (自动化配药设备市场), French (Marché des dispositifs automatisés de préparation magistrale), German (Markt für automatisierte Compoundiergeräte), and Italian (Mercato dei dispositivi di compounding automatizzati), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/71627

Our More Reports:

Fragile X Syndrome (FXS) Market
https://exactitudeconsultancy.com/reports/71653/fragile-x-syndrome-fxs-market

Hereditary Angioedema Market
https://exactitudeconsultancy.com/reports/71655/hereditary-angioedema-market

Limb Girdle Muscular Dystrophy (LGMD) Market
https://exactitudeconsultancy.com/reports/71657/limb-girdle-muscular-dystrophy-lgmd-market

Morquio Syndrome Market
https://exactitudeconsultancy.com/reports/71659/morquio-syndrome-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Automated Compounding Devices Market was valued at USD 445 million in 2024 and is projected to reach USD 920 million by 2034 here

News-ID: 4307958 • Views:

More Releases from Exactitude Consultancy

Lupus Nephritis Patient Pool Analysis Market is projected to reach USD 2.58 billion by 2034
Lupus Nephritis Patient Pool Analysis Market is projected to reach USD 2.58 bill …
The global Lupus Nephritis (LN) Patient Pool Analysis Market was valued at USD 1.27 billion in 2024 and is projected to reach USD 2.58 billion by 2034, expanding at a CAGR of 7.4% during the forecast period (2025-2034). Growth is fueled by the rising incidence of systemic lupus erythematosus (SLE), increasing disease awareness, improved access to immunology specialists, expanding biomarker testing, and growing adoption of biologics and targeted therapies that
Gastroesophageal Junction (GEJ) Adenocarcinoma Market is projected to reach USD 4.33 billion by 2034
Gastroesophageal Junction (GEJ) Adenocarcinoma Market is projected to reach USD …
The global Gastroesophageal Junction (GEJ) Adenocarcinoma Market was valued at USD 1.96 billion in 2024 and is projected to reach USD 4.33 billion by 2034, growing at a CAGR of 8.1% during the forecast period (2025-2034). The market is expanding due to rising incidence of GEJ cancers, increasing adoption of biomarker-driven therapies, improved diagnostic imaging, and strong clinical uptake of immunotherapy and targeted agents. Download Full PDF Sample Copy of Market
Lymphoedema Market was valued at USD 1.25 billion in 2024 and is projected to reach USD 2.40 billion by 2034
Lymphoedema Market was valued at USD 1.25 billion in 2024 and is projected to re …
Market Overview The Lymphoedema Market was valued at USD 1.25 billion in 2024 and is projected to reach USD 2.40 billion by 2034, growing at a CAGR of 6.6% throughout the forecast period. Lymphoedema is a chronic condition characterized by abnormal swelling due to lymphatic system dysfunction. It may be primary (genetic) or secondary, commonly caused by cancer treatments such as lymph node removal or radiation therapy. Rising cancer prevalence, increasing obesity
Ovarian Cancer Market is projected to reach USD 15.96 billion by 2034
Ovarian Cancer Market is projected to reach USD 15.96 billion by 2034
The global Ovarian Cancer Market was valued at USD 8.12 billion in 2024 and is projected to reach USD 15.96 billion by 2034, growing at a CAGR of 6.9% during the forecast period (2025-2034). Market growth is driven by rising incidence of epithelial ovarian cancer, increased use of genetic and biomarker testing, strong uptake of targeted therapies (PARP inhibitors, angiogenesis inhibitors), and growing awareness of early detection strategies. Download Full PDF

All 5 Releases


More Releases for Automated

Automated Fiber Placements And Automated Tape Laying (AFP- ATL) Machines Market …
According to Market Research Intellect, the global Automated Fiber Placements And Automated Tape Laying (AFP- ATL) Machines market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for automated tape laying (ATL) and automated fiber
Ace Automated Gates | Austin Enhances Security with Premium Automated Gate Solut …
Ace Automated Gates | Austin enhances property security with premium automated gate solutions. Specializing in gate installation, repair, and advanced access control systems, they provide high-quality electric and motorized gates for residential and commercial properties. Offering expert craftsmanship and durable materials, they ensure long-lasting security and convenience. Austin, TX - Home and business owners seeking enhanced security, convenience, and style can now rely on Ace Automated Gates | Austin [https://aceautomatedgatesaustin.com/] for
Automated Autoinjectors Market
The "Automated Autoinjectors Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Automated Autoinjectors Market, 2024-2031 Verified Market Research's most recent report, "Automated Autoinjectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides an in-depth examination
Automated Journalism Market All Sets for Continued Outperformance: Automated Ins …
HTF MI introduces new research on Automated Journalism covering the micro level of analysis by competitors and key business segments (2024-2030). The Automated Journalism explores a comprehensive study of various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing. Some of the major key players profiled
Automated Fiber Placements and Automated Tape Laying (AFP- ATL) Machines Market …
Automated fiber placement and automated tape laying machines are used for the fabrication of composites parts used in aerospace and defense industries. These machines help in precisely placing fiber tapes, tows and sheets on molds or cores to manufacture composite parts with high strength and lightweight properties. Market Dynamics: Increasing demand from aerospace and defense industry is one of the major factors estimated to boost the growth of the AFP- ATL machines
Automated Microbiology Market - Efficiency Meets Accuracy: Redefining Microbiolo …
Newark, New Castle, USA: The "Automated Microbiology Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Automated Microbiology Market: https://www.growthplusreports.com/report/automated-microbiology-market/7801 This latest report researches the industry structure, sales, revenue,